Immediate Impact

38 standout
Sub-graph 1 of 19

Citing Papers

The future of pharmaceuticals: Artificial intelligence in drug discovery and development
2025 Standout
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
2024 Standout
2 intermediate papers

Works of P.D. Siviero being referenced

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry
2014
Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
2013

Author Peers

Author Last Decade Papers Cites
P.D. Siviero 397 45 57 48 13 484
Anna Bucsics 395 98 33 22 27 537
Roberta Joppi 307 96 21 21 15 421
Kim Saverno 116 48 64 49 29 475
Thomas Michaeli 227 38 24 24 39 422
Randy J. Levitt 222 16 113 27 8 504
Karen Van Nuys 119 37 53 16 23 558
Ashlyn Pinto 254 32 32 20 10 413
Cherie Paquette 136 31 16 11 28 471
Andrae Vandross 224 22 106 18 18 529
John J. Ko 98 61 50 21 23 414

All Works

Loading papers...

Rankless by CCL
2026